Mogi and colleagues addressed an increment in levels of epidermal growth factor (EGF), transforming growth factor α (TGFα), interleukins (IL)-1β, and IL-6 in the striatum and cerebrospinal fluid (CSF) of PD patients [2,3]. The gene discussed is IL6; the disease is Parkinson disease.